Cargando…

3.0T Cardiac Magnetic Resonance Quantification of Myocardial Extracellular Volume using different delay time of post-contrast T1 mapping for the Diagnosis of Cardiac Amyloidosis

Detalles Bibliográficos
Autores principales:	Lin, Lu, Wang, Yining, Cao, Jian, Kong, Lingyan, An, Jing, Zhang, Tianjing, Spottiswoode, Bruce S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032604/ http://dx.doi.org/10.1186/1532-429X-18-S1-P316

Ejemplares similares

3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis
por: Liu, Yumeng, et al.
Publicado: (2022)

Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis
por: Treibel, Thomas A., et al.
Publicado: (2015)

Can myocardial susceptibility quantification be an imaging biomarker for cardiac amyloidosis?
por: Hayashi, Hidetaka, et al.
Publicado: (2021)

Novel quantification of extracellular expansion by cardiac magnetic resonance is a robust marker in diagnosis of cardiac amyloidosis
por: Mongeon, Francois-Pierre, et al.
Publicado: (2011)

Semi-Quantification of Myocardial Uptake of Bone-Seeking Agents in Suspected Cardiac Amyloidosis
por: Campi, Cristina, et al.
Publicado: (2023)

Late Iodine Enhancement and Extracellular Volume Fraction in Cardiac Amyloidosis by Computed Tomography
por: Suzuki, Masataka, et al.
Publicado: (2022)

Quantification of extracellular volume fraction by cardiac computed tomography for noninvasive assessment of myocardial fibrosis in hemodialysis patients
por: Yamada, Akimasa, et al.
Publicado: (2020)

Quantification of (11)C-PIB kinetics in cardiac amyloidosis
por: Kero, Tanja, et al.
Publicado: (2018)

Cardiac extracellular volume quantified with T1 mapping techniques reflects degree of cardiac and neurological involvement in Hereditary Transthyretin Amyloidosis
por: González-López, Esther, et al.
Publicado: (2015)

Myocardial Wringing and Rigid Rotation in Cardiac Amyloidosis
por: Mora, Vicente, et al.
Publicado: (2022)

Effect of contrast dose, post-contrast acquisition time, myocardial regionality, cardiac cycle and gender on dynamic-equilibrium CMR measurement of myocardial extracellular volume
por: Miller, Christopher A, et al.
Publicado: (2013)

3.0T motion-corrected single-shot phase sensitive inversion recovery (PSIR) late gadolinium enhancement (LGE) in free-breathing patients compared with conventional segmented breath-held LGE
por: Lin, Lu, et al.
Publicado: (2015)

Amyloid Deposits and Fibrosis on Left Ventricular Endomyocardial Biopsy Correlate With Extracellular Volume in Cardiac Amyloidosis
por: Pucci, Angela, et al.
Publicado: (2021)

Delayed Diagnosis of Cardiac Amyloidosis Secondary to Multiple Myeloma
por: Qatanani, Ahmad, et al.
Publicado: (2021)

DPD Quantification in Cardiac Amyloidosis: A Novel Imaging Biomarker
por: Scully, Paul R., et al.
Publicado: (2020)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
por: Banypersad, Sanjay M, et al.
Publicado: (2012)

Automated inline extracellular volume (ECV) mapping
por: Spottiswoode, Bruce S, et al.
Publicado: (2015)

Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis
por: Clemmensen, Tor Skibsted, et al.
Publicado: (2018)

Cardiac MR elastography for quantitative assessment of elevated myocardial stiffness in cardiac amyloidosis
por: Arani, Arvin, et al.
Publicado: (2017)

Cardiac Amyloidosis
por: Elbdri, Salah, et al.
Publicado: (2021)

Extracellular Volume Fraction Based on Cardiac Magnetic Resonance T1 Mapping: An Effective Way to Evaluate Cardiac Injury Caused by Cardiac Amyloidosis in Patients with Multiple Myeloma
por: Liu, Minghui, et al.
Publicado: (2022)

Role of cardiac T1 mapping and extracellular volume in the assessment of myocardial infarction
por: Garg, Pankaj, et al.
Publicado: (2018)

Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping
por: Ioannou, Adam, et al.
Publicado: (2023)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)

Abnormal Myocardial Blood Flow Reserve Observed in Cardiac Amyloidosis
por: Nam, Michael Chi Yuan, et al.
Publicado: (2016)

Contrast-enhanced whole-heart coronary MRA at 3.0T for the evaluation of cardiac venous anatomy
por: Ma, Heng, et al.
Publicado: (2010)

Regional left ventricular myocardial T1 and velocity mapping: elevated extracellular volume fraction is associated with altered myocardial velocities
por: Collins, Jeremy D, et al.
Publicado: (2014)

Atrial delayed enhancement is associated with the severity of diastolic dysfunction in cardiac amyloidosis
por: Pozo, Eduardo, et al.
Publicado: (2013)

Double Delayed Enhancement: Concomitant Cardiac Amyloidosis and Acute Coronary Embolism
por: Ahmed, Talha, et al.
Publicado: (2021)

Base-to-apex gradient pattern of cardiac impairment identified on myocardial T1 mapping in cardiac amyloidosis
por: Oda, Seitaro, et al.
Publicado: (2018)

Feasibility study of a novel acquisition technique of cardiac cine magnetic resonance imaging in patients with atrial fibrillatio
por: Cao, Jian, et al.
Publicado: (2015)

Catastrophic Cardiac Amyloidosis
por: Panduranga, Prashanth, et al.
Publicado: (2010)

Occult cardiac amyloidosis?
por: Westin, Oscar, et al.
Publicado: (2019)

Arrhythmias in Cardiac Amyloidosis
por: John, Roy M.
Publicado: (2018)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Fulminant cardiac amyloidosis
por: Real, Carlos, et al.
Publicado: (2021)

Cardiac Amyloidosis Treatment
por: Stern, Lily K., et al.
Publicado: (2022)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Dual versus single energy cardiac CT to measure extra cellular volume in cardiac amyloidosis: Correlations with cardiac MRI
por: Tavoosi, Anahita, et al.
Publicado: (2022)

Delayed hyper-enhancement cardiac magnetic resonance provides incremental prognostic value in patients with cardiac amyloidosis
por: Austin, Bethany A, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_i2i9q1q96ecaqc0scl0o2q4ftl